Cadence Capital Management’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Cadence Capital Management’s Portfolio HPTX Stock Details HPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-30,780	Closed	-$1.41M	–	713
2015 Q1	$1.41M	Buy	+30,780	New	+$921K	0.09%	298
2014 Q4	–	Sell	-22,030	Closed	-$556K	–	700
2014 Q3	$556K	Buy	+22,030	New	+$547K	0.03%	484

Cadence Capital Management's HPTX Position: Q2 2015 in Review

Cadence Capital Management sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 30,780 shares — an estimated $1.41M sold.

Cadence Capital Management first reported a position in HPTX in Q3 2014 and held it in 2 quarters. The position peaked at $1.41M in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

Cadence Capital Management reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Cadence Capital Management sold 30,780 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $1.41M.
Cadence Capital Management first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q3 2014 and held it in 2 quarters.
Cadence Capital Management's HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $1.41M in Q1 2015.
0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Cadence Capital Management's 13F filing for Q2 2015, filed 11 Aug 2015.